ethics and corporate responsibility

13
Running head: ETHICS AND CORPORATE RESPONSIBILITY 1 Ethics and Corporate Responsibility in the Workplace and the World John Simpson Professor Steve Harris Law, Ethics and Corporate Governance November 21, 2014

Upload: john-simpson

Post on 08-Nov-2015

20 views

Category:

Documents


4 download

DESCRIPTION

Legal Paper on Ethics

TRANSCRIPT

Running head: ETHICS AND CORPORATE RESPONSIBILITY 1 ETHICS AND CORPORATE RESPONSIBILITY 2

Ethics and Corporate Responsibility in the Workplace and the WorldJohn SimpsonProfessor Steve Harris Law, Ethics and Corporate GovernanceNovember 21, 2014

1. Describe the key characteristics of a stakeholder and determine all the stakeholders within the PharmaCARE scenario. Stakeholders are persons or parties that have a vested interest in the business of the organization. There are three types of stakeholders and they are primary, secondary and key stakeholders. A primary stakeholder is an individual or party who stands to be directly affected whether good or bad by the actions of the organization. They have a major interest in the success of an organization (Bonner, 2010). Secondary stakeholders are folks who may be indirectly affected by the actions of the group or organization and key stakeholders are individuals who can have a positive or negative affect while being key decision makers in the organization. One example of a key stakeholder could be an outreach worker who works directly with individuals and they typically carry out the work, behavior or effort. PharmaCARE has several stakeholders which include the CEO of PharmaCare, the several healers, the Colberians, Allen Jones, Medicare, Medicaid, and VA patients, hospitals, consumers, and employees of PharmaCare and CompCare. 2. Analyze the human rights issues presented by PharmaCAREs treatment of the Colberias indigenous population versus that of its executives. Recommend at least three (3) changes PharmaCARE can make to be more ethical going forward. PharmaCARE launched the newer initiative, We CARE about YOUR world, pledging their guarantee towards the environment by packaging changes, recycling and all other green initiatives. It has been in the complete contrast towards treatment of Colberians and rank & file workers of the PharmaCARE. Publicly PharmaCARE shows the ethical persona about the green corporation, which CAREs about YOUR world. Contradictory occurrences have been low wages given to the population of the underdeveloped nation of the Colberia in the amount of $1.00 a day, harvesting plants by walking 5 miles in & out of the jungle and carrying the baskets that weigh up to 50 pounds. Also there have been instances where the deterioration of the Colberian environment has been nonchalant. Another instance has been the choice of management ignoring the dilemma of the production technicians unhealthy work culture by having mold in the interior air vents. PharmaCAREs executives live within the luxury compound, which includes swimming pools, tennis courts and golf courses. The internal situation has been immoral, unethical and socially irresponsible how the Colberians are being treated, along with rank & file workers of the PharmaCARE in stark comparison to the PharmaCAREs executives. Three changes that PharmaCARE can incorporate to be more ethical going forward are making benefits that are income-tested for all age groups and they should be applied equally across all disease circumstances. Next protecting low-income earners is an essential part, as financial barriers can actually lead to increased overall costs. There should be no out-of-pocket costs for very low income individuals. Finally the rules and policies of the PharmaCARE program need to be easy and the true costs of prescription drugs should be made more apparent to recipients (Oetter, 2003). 3. Assess PharmaCAREs environmental initiative against the backdrop of its anti-environmental lobbying efforts and Colberian activities. Support the position.Even if PharmaCARE has positive contributions with its charitable discounts along with free drugs towards lower income clients, and its foundation, which sponsors the healthcare educational programs and also gives scholarships that has just been for the show. They have proven that they are being hypocritical by literally stealing Colebrias indigenous cures without compensating the people for their natural discovery. PharmaCARE has developed a reputation that they have a positive impact on the society as well as the culture. They have vowed that they are working to protect the environment by recycling, packaging changes along with the rest of the green initiatives. However their lobbying efforts have really been focused on trying to defeat the environmental laws along with regulations. They have been involved in the some kind of green marketing that has been utilized for promoting perception, which the companys products along with their policies have been environmentally friendly, in addition they have been called the green washing. Green washing efforts may begin from changing the name/label of the product for evoking natural culture on the product, which encompasses harmful chemicals towards multimillion dollar advertising campaigns thus portraying very polluting energy organizations like ecofriendly. They have been exploiting people of Colberia because of the lower standard of living within Colberia. PharmaCAREs activities within Colberia have been a brilliant light which shows that they care as long as it does not affect their profit margin. Actual company responsibility of organizations that claim to be responsible do not just concentrate on its individual internal policies it also thinks of ways to alter rules of the game along with developing the more level playing field that makes it feasible for all organizations to behave much more responsibly (Halbert & Ingulli, Law & Ethics in Business Environment, 2011). 4. Decide whether or not PharmaCAREs actions with respect to the indigenous people of Colberia would be ethical in accordance with each of the following ethical theories:

a. UtilitarianismPharmaCARE is not employing the utilitarianism approach. This approachtowards ethics describes that ethically accurate behavior has not been associated toany absolute ethical/moral value however to the evaluation of consequences of the provided action to those who would be affected through that.b. DeontologyPharmaCAREs actions do not correspond with the deontology as this theory states that we have the duty to be dependent onthe rules. Such ethical theory describes that each & every human being possesses some moral rights along with duties as well as ethical choices derive from the universal principles depending on such rights along with duties.c. Virtue ethicsImplementing virtue ethics theory towards PharmaCARE Company is not correct either. This theory describes that our virtues have remained a matter of the best habits, established training along with recurrence with the individual communities.d. Ethics of careEthics of care has been the theory that revolves around interdependence of all parties involved. This bears assumption, which society along with the public have been separate along with vulnerability which differs with separate people. Its practice supports those ethics about care even though its services have higher impacts on lives of the patients and this cant be majorly positive as the scenario depicts.e. Your own moral / ethical compass PharmaCARE utilizes Colberias intellectual property without appropriate payment or acknowledgementand I do not agree with the individual personal ethics/moral compass. It is not right to deplete resources of the field and not aiding the area to help rebuild. Executives have been living quite well by destroying the natural culture of these African nations and unfortunately the inhabitants have not been that fortunate. With PharmaCARE utilizing the Colberia intellectual property falls in line to the ethical theory ethics of care.5. Compare PharmaCAREs actions with those of at least one (1) real-world company, whose corporate activities led to ethical, environmental, or workplace safety issues and financial loss. Analyze the similarities and differences between PharmaCARE and the company that you chose.The company Pfizer has faced a similar scenario with the drug Torcetrapid. They had been in the lead of mass marketing drugs along with getting their sales force in front of the doctors for persuading them to utilize Pfizer's products rather than that of any of its rivals. When their research labs were not productive, Pfizer had to come up with something else to help since they had not developed anything since Viagra. Pfizer had been banking on a new drug it had produced named Torcetrapib, which was concentrated on treating hypercholesterolemia and prevent cardiovascular disease. However in 2006, they stopped producing when the early data showed that there was an increase in cardiovascular events when it was shown that it increased systolic blood pressure. The early reports revealed that blood pressure had increased by 2 to 3 mm Hg. With such an increase it could translate into a 20% higher stroke mortality and 12% from ischemic heart disease (O'Riordan, 2006). In conclusion it is the responsibility of these organizations to promote good business practices at each level of the business. This business should be done honestly and ethically right to prevent further problems that could possibly cause harm to the public. They should foster a healthy environment and comply with all the rules that apply to them.

REFERENCESBonner, T. (2010, October 28). Stakeholders in Project Management. Retrieved from Bright Hub PM: http://www.brighthubpm.com/project-planning/93262-stakeholders-in-project-management/Halbert, T., & Ingulli, E. (2011). Law & Ethics in Business Environment. Mason: Cengage Learning.Oetter, H. M. (2003, April). PharmaCare Changes are Fair. Retrieved from BC Medical Journal: http://www.bcmj.org/editorials/pharmacare-changes-are-fairO'Riordan, M. (2006, December 4). Torcetrapid Torpedoed: Increased Risk of Mortality, Cardiovascular Events Ends Development. Retrieved from Medscape: http://www.medscape.com/viewarticle/788917